The Problem We're Solving
MyRxWallet is building the trust, consent, and credential layer for the entire U.S. healthcare system. ONC-certified to 317/317 criteria. Live blockchain since January 2025. 13 active API partnerships including Kaiser Permanente, VA, CMS, and Epic. No one is building what we are building.
No commitment until SEC qualification. Your information is secure and will not be shared. By registering you consent to receive offering updates from MyRxWallet.
No Consent, No Access
Every data access requires patient-signed consent recorded permanently on-chain
ONC 2015 Cures Certified
317/317 criteria met — the federal government's highest health IT certification standard
Patient-Owned Identity
MyRx-ID: the first soulbound non-transferable health identity credential on a live U.S. blockchain
The Problem We're Solving
Why MyRxWallet
Every day, patients sit in exam rooms unable to tell their doctor what medications they take. Health records are scattered across systems that cannot talk to each other. And when breaches happen — Change Healthcare (145M patients), Ascension Health (5.6M), UnitedHealth Group — patients find out from the news, not from their doctor. The root cause: your health data was never yours. MyRxWallet changes that at the infrastructure level — the consent, credential, and evidence layer that makes your health identity permanently yours.
The highest level of federal health IT certification. Fewer than 200 products worldwide hold it. We do. This is the prerequisite for every federal health contract.
MyRx-Mainnet Chain 8472 has been running for 18 months. 1.28M+ blocks. 98.7% uptime. 2,914 active patient credentials. This is a live product, not a concept.
Kaiser Permanente, VA Lighthouse, CMS Blue Button 2.0, Anthem, UnitedHealthcare, Epic, athenahealth, Oracle Health, Molina, Cigna, Indian Health Service — and growing.
No other company on the GSA Multiple Award Schedule combines ONC 317/317 certification, a live blockchain, and active federal API integrations. The category is ours.
GSA Multiple Award Schedule offer submitted. 7 SINs. 120 labor categories. Direct procurement vehicle for VA, HHS, CMS, DHS, and every federal health agency.
Women-Owned Small Business, Minority-Owned, Asian-Pacific American Owned. Unlocks billions in federal set-aside procurement pools inaccessible to most competitors.
18-Month Post-Funding Roadmap
Opens the full electronic prescribing for controlled substances market — adding 30% to our total addressable market immediately.
Unlocks enterprise and payer sales channels. Required by major hospital systems and insurance companies for vendor approval.
Makes MyRxWallet visible to every federal agency on the federal marketplace. Direct path to VA, HHS, CMS, DHS enterprise contracts.
Federally Qualified Health Centers serve underserved communities nationwide. First signed contracts establish a referenceable, auditable revenue base.
Conservative annual recurring revenue target from FQHC contracts and GSA task orders. Full offering proceeds accelerate timeline significantly.
S-1 filing initiated post-funding. OTCQB listing followed by path to Nasdaq uplisting for full public market liquidity for shareholders.
Use of Proceeds
Strategic M&A
Platform ecosystem acquisitions — DEA EPCS, FedRAMP, SOC 2 team and infrastructure
EHR Development
Sovereign credential infrastructure and FHIR R4 API layer continued development
Working Capital
Team, operations, and infrastructure to support commercial launch
Legal & Regulatory
SEC compliance, IP filings, patent prosecution, regulatory engagement
Prana Data Center
India land acquisition for Prana data center infrastructure
MyRxWallet is offering up to 882,127 shares at $85.00 per share. Maximum offering $74.98M. Register your interest today.
Register Interest — $85.00 / ShareIMPORTANT — DRAFT DOCUMENT — NOT FOR PUBLIC DISTRIBUTION
REGULATION A OFFERING — NOT YET QUALIFIED BY THE SEC. An offering statement on Form 1-A has been filed with the U.S. Securities and Exchange Commission (CIK: 0002041886) but has not yet been qualified by the SEC. This page does not constitute an offer to sell or a solicitation of an offer to buy these securities. No money or other consideration is being solicited, and if sent, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is qualified, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance given after the qualification date.
FORWARD-LOOKING STATEMENTS. This page contains forward-looking statements, including milestones, revenue targets, market opportunity projections, and business plans. These statements involve known and unknown risks and uncertainties. Actual results may differ materially from those expressed or implied. Past performance of any referenced transaction is not indicative of future results. Investing in early-stage companies involves significant risk of total loss of principal.
NO GOVERNMENT ENDORSEMENT. References to ONC certification, GSA, VA, CMS, HHS, NIH, and other government programs are factual recitations of registration and application status only and do not imply endorsement, approval, or affiliation by any U.S. government agency.
This page is a draft prepared for review by Business Legal Advisors and securities counsel prior to SEC qualification. It must not be distributed publicly or used to solicit investment prior to SEC qualification of the offering and approval by securities counsel. Prospective investors must review the full offering circular on SEC EDGAR (CIK: 0002041886) before making any investment decision. MyRxWallet North America Corporation | 2475 S Jones Blvd STE 9 | Las Vegas, Nevada 89146 | olivia@myrxwallet.io
